# Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia

> **NCT00661726** · PHASE2 · COMPLETED · sponsor: **Carelon Research** · enrollment: 6 (actual)

## Conditions studied

- Thalassemia

## Interventions

- **DRUG:** Decitabine (USAN, INN)

## Key facts

- **NCT ID:** NCT00661726
- **Lead sponsor:** Carelon Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661726, "Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00661726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*